Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer by Dauplat, J, Chene, G, Pomel, C, Dauplat, M.M, Bouëdec, G.Le, Mishellany, F, Lagarde, N, Bignon, Y.J, Jaffeux, P, Aublet-Cuvelier, B, Dechelotte, P, Pouly, J.L, Penault-Llorca, F

Get full text

9435 POSTER A New Promising Strategy in Chondrosarcoma – Quaternary Ammonium as Vector of Radioisotopes and Cytotoxics Toward Cartilage Proteoglycans by Pevrode, C, David, E, Vidal, A, Auzeloux, P, Communal, Y, Dauplat, M.M, Besse, S, Redini, F, Miot-Noirault, E, Weber, V

Get full text

Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category by Gimbergues, P, Dauplat, M.M, Cayre, A, Durando, X, Le Bouedec, G, Finat-Duclos, F, Portefaix, G, Kwiatkowski, F, Dauplat, J, Penault-Llorca, F, Tchirkov, A

Get full text

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer by Nabholtz, J.M., Chalabi, N., Radosevic‐Robin, N., Dauplat, M.M., Mouret‐Reynier, M.A., Van Praagh, I., Servent, V., Jacquin, JP, Benmammar, K.E., Kullab, S., Bahadoor, M.R.K., Kwiatkowski, F., Cayre, A., Abrial, C., Durando, X., Bignon, Y.J., Chollet, P., Penault‐Llorca, F.

Get full text

Ovarian epithelial dysplasia after ovulation induction: time and dose effects by Chene, G., Penault-Llorca, F., Le Bouëdec, G., Mishellany, F., Dauplat, M.M., Jaffeux, P., Aublet-Cuvelier, B., Pouly, J.L., Dechelotte, P., Dauplat, J.

Get full text

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer: Phase II Study of Cetuximab Combined with Docetaxel fo... by Nabholtz, J.M., Chalabi, N., Radosevic-Robin, N., Dauplat, M.M., Mouret-Reynier, M.A., Van Praagh, I., Servent, V., Jacquin, JP, Benmammar, K.E., Kullab, S., Bahadoor, M.R.K., Kwiatkowski, F., Cayre, A., Abrial, C., Durando, X., Bignon, Y.J., Chollet, P., Penault-Llorca, F.

Get full text